Filitra 20 Fortune Health Care: Compound Profile
Filitra 20 Fortune Health Care is a research-grade pharmaceutical compound containing vardenafil as the active ingredient, formulated for in-vitro laboratory investigations. This phosphodiesterase type 5 (PDE5) inhibitor represents a valuable tool for researchers examining vascular smooth muscle mechanisms and cyclic guanosine monophosphate (cGMP) pathway modulation in cellular models. Scientists at Stroid UK Shop utilise this compound to investigate the molecular mechanisms underlying PDE5 inhibition and its effects on intracellular signalling cascades.
Laboratory Applications
Research applications focus on the compound’s selective inhibition of phosphodiesterase type 5 enzyme activity in smooth muscle cell cultures. Laboratory studies examine how vardenafil modulates cGMP degradation, leading to increased cyclic nucleotide concentrations and subsequent protein kinase activation pathways. Researchers investigating cardiovascular physiology utilise this compound to study vasodilation mechanisms in isolated tissue preparations. The formulation proves particularly valuable for comparative studies alongside other vardenafil research compounds, enabling detailed pharmacological profiling. Additional research areas include endothelial function studies, nitric oxide pathway investigations, and cellular calcium handling mechanisms in vascular smooth muscle preparations.
Analytical Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Vardenafil |
| Strength | 20mg per unit |
| Manufacturer | Fortune Health Care |
| Chemical Class | PDE5 Inhibitor |
| Molecular Formula | C₂₃H₃₂N₆O₄S |
| Molecular Weight | 488.60 g/mol |
| Storage Conditions | Room temperature, dry environment |
Researchers studying metabolic pathways may also investigate complementary compounds from our SARM research collection and peptide research portfolio for comprehensive experimental designs.
Research Compliance
This product is strictly intended for in-vitro research purposes only and is not approved for human consumption, therapeutic use, or clinical application. All laboratory investigations must comply with institutional research guidelines and appropriate safety protocols.
